{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:35:29Z","timestamp":1788820529481,"version":"build-2803163510"},"reference-count":24,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2017]]},"DOI":"10.7883\/yoken.jjid.2016.133","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T22:17:52Z","timestamp":1472595472000},"page":"235-238","source":"Crossref","is-referenced-by-count":40,"title":["Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of &lt;i&gt;Brucella&lt;\/i&gt; Isolates in Hamedan, Iran"],"prefix":"10.7883","volume":"70","author":[{"given":"Fatemeh","family":"Torkaman Asadi","sequence":"first","affiliation":[{"name":"Brucellosis Research Center, Hamedan University of Medical Sciences"},{"name":"Blood Transfusion Research Center, High Institute for Research; Education in Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Hamid","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Brucellosis Research Center, Hamedan University of Medical Sciences"},{"name":"Division of Infectious Diseases, Sina Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Yousef","family":"Alikhani","sequence":"additional","affiliation":[{"name":"Brucellosis Research Center, Hamedan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Moghimbeigi","sequence":"additional","affiliation":[{"name":"Brucellosis Research Center, Hamedan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Naseri","sequence":"additional","affiliation":[{"name":"Blood Transfusion Research Center, High Institute for Research; Education in Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Musallam II, Abo-Shehada MN, Hegazy YM, et al. Systematic review of brucellosis in the Middle East: disease frequency in ruminants and humans and risk factors for human infection. Epidemiol Infect. 2016;144:671-85.","DOI":"10.1017\/S0950268815002575"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kracalik IT, Abdullayev R, Asadov K, et al. Human brucellosis trends: re-emergence and prospects for control using a one health approach in Azerbaijan (1983\u20132009). Zoonoses Public Health. 2016;63:294-302.","DOI":"10.1111\/zph.12229"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kassiri H, Amani H, Lotfi M. Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran. Asian Pac J Trop Biomed. 2013;3:589-94.","DOI":"10.1016\/S2221-1691(13)60121-5"},{"key":"4","unstructured":"4. Zeinali M, Nabavi M, Shirzadi MR, et al. Epidemiological situation of brucellosis in the past three decades in Iran. Iran J Public Health. 2014;43:24."},{"key":"5","unstructured":"5. Leylabadlo HE, Bialvaei AZ, Samadi Kafil H. Brucellosis in Iran: why not eradicated? Clin Infect Dis. 2015;61:1629-30."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrobial Agents. 2010;36 Suppl 1:S12-7.","DOI":"10.1016\/j.ijantimicag.2010.06.014"},{"key":"7","unstructured":"7. Van Bambeke F, Barcia-Macay M, Lemaire S, et al. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr Opin Drug Discov Devel. 2006;9:218-30."},{"key":"8","unstructured":"8. Joint Food and Agriculture Organization (FAO)\/World Health Organization (WHO). Expert committee on brucellosis. World Health Organ Tech Rep Ser. 1986;740:1-132."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Skalsky K, Yahav D, Bishara J, et al. Treatment of human brucellosis: systematic review and meta-analysis of randomized controlled trials. BMJ. 2008;336:701-4.","DOI":"10.1136\/bmj.39497.500903.25"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis. 2012;16:e247-51.","DOI":"10.1016\/j.ijid.2011.12.003"},{"key":"11","unstructured":"11. Beeching NJ, Corbel MJ. Brucellosis. In: Kasper DL, Fauci AS, Hauser SL, et al. editors. Harrison\u2019s Principles of Internal Medicine, 19th edn. New York: McGraw Hill; 2015. p. 194e:1-5."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Abdel-Maksoud M, House B, Wasfy M, et al. In vitro antibiotic susceptibility testing of <i>Brucella<\/i> isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance. Ann Clin Microbiol Antimicrob. 2012;11:24.","DOI":"10.1186\/1476-0711-11-24"},{"key":"13","unstructured":"13. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial and susceptibility testing: 24th informational supplement. Document M100-S24 (M02-A11). Wayne, PA: CLSI; 2014."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Turan H, Serefhanoglu K, Karadeli E, et al. Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey. Intern Med. 2011;50:421-8.","DOI":"10.2169\/internalmedicine.50.4700"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Arkun R, Mete BD. Musculoskeletal brucellosis. Semin Musculoskelet Radiol. 2011;15:470-9.","DOI":"10.1055\/s-0031-1293493"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hashemi SH, Keramat F, Ranjbar M, et al. Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran. Int J Infect Dis. 2007;11:496-500.","DOI":"10.1016\/j.ijid.2007.01.008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Maves RC, Castillo R, Guillen A, et al. Antimicrobial susceptibility of <i>Brucella<\/i> <i>melitensis<\/i> isolates in Peru. Antimicrob Agents Chemother. 2011;55:1279-81.","DOI":"10.1128\/AAC.00979-10"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Jiang H, Mao LL, Zhao HY, et al. MLVA typing and antibiotic susceptibility of <i>Brucella<\/i> human isolates from Liaoning, China. Transact R Soc Trop Med Hyg. 2010;104:796-800.","DOI":"10.1016\/j.trstmh.2010.08.002"},{"key":"19","unstructured":"20. Etiz P, Kibar F, Ekenoglu Y, et al. Characterization of antibiotic susceptibility of <i>Brucella<\/i> spp. isolates with E-test method. Arch Clin Microbiol. 2015;6:1:1."},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Hashim R, Ahmad N, Mohamed Zahidi J, et al. Identification and in vitro antimicrobial susceptibility of <i>Brucella<\/i> species isolated from human brucellosis. Int J Microbiol. 2014;2014:596245.","DOI":"10.1155\/2014\/596245"},{"key":"21","unstructured":"22. Rashidi K, Motaharinia Y, Rezai M, et al. Determination of antibiotic resistance of <i>Brucella<\/i> spp. isolated from brucellosis patients in Kurdistan. J Large Animal Clin Sci Res. 2011;4:41-8. Persian."},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Deshmukh A, Hagen F, Sharabasi OA, et al. In vitro antimicrobial susceptibility testing of human <i>Brucella<\/i> <i>melitensis<\/i> isolates from Qatar between 2014\u20132015. BMC Microbiol. 2015;15:121.","DOI":"10.1186\/s12866-015-0458-9"},{"key":"23","unstructured":"24. Neto AM, Cor\u00e7\u00e3o G, Dasso MG, et al. Antimicrobial susceptibility profile of <i>Brucella<\/i> spp. isolated in Brazil. Rev Patol Trop. 2014;43:163-72."},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Barbosa Pauletti R, Reinato Stynen AP, Pinto da Silva Mol J, et al. Reduced susceptibility to rifampin and resistance to multiple antimicrobial agents among <i>Brucella abortus<\/i> isolates from cattle in Brazil. PLoS One. 2015;10:e0132532.","DOI":"10.1371\/journal.pone.0132532"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/3\/70_JJID.2016.133\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:41:48Z","timestamp":1568342508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/3\/70_JJID.2016.133\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2016.133","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}